| Literature DB >> 27493957 |
Roodabeh Koodaryan1, Ali Hafezeqoran1.
Abstract
Background. It is important to understand the influence of different collar designs on peri-implant marginal bone loss, especially in the critical area. Objectives. The purpose of the present systematic review and meta-analysis was to compare dental implants with different collar surfaces, evaluating marginal bone loss and survival rates of implants. Methods. Eligibility criteria included clinical human studies, randomized controlled trials, and prospective and retrospective studies, which evaluated dental implants with different collar surface in the same study. Results. Twelve articles were included, with a total of 492 machined, 319 rough-surfaced, and 352 rough-surfaced microthreaded neck implants. There was less marginal bone loss at implants with rough-surfaced and rough-surfaced microthreaded neck than at machined-neck implants (difference in means: 0.321, 95% CI: 0.149 to 0.493; p < 0.01). Conclusion. Rough and rough-surfaced microthreaded implants are considered a predictable treatment for preserving early marginal bone loss.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27493957 PMCID: PMC4963580 DOI: 10.1155/2016/4987526
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Diagram of the search strategy.
Characteristics of studies included (n = 12).
| Author, year | Arch | Study design | Follow-up time | Patients ( | Patients' age | Collar surface characterization | Implants system | Collar | Implants ( | MBL (mm) | Survival rate (%) | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diameter (mm2) | Length (mm) | <5 y | 5–10 y | >10 y | ||||||||||
| den Hartog et al. 2013 [ | Maxilla | RCT | 1 year | 93 | 37.2 ± 12.9 | Machined | Noble Biocare | — | 1.5 | 30 | 1.19 ± 0.82 | — | — | 96.8 |
| 40.1 ± 14.4 | Rough microthreaded | Noble Biocare | — | — | 31 | 0.90 ± 0.57 | — | — | 100 | |||||
| 40.1 ± 17.2 | Scalloped microthreaded | Noble Biocare | — | — | 31 | 2.01 ± 0.74 | — | — | 100 | |||||
|
| ||||||||||||||
| Nickenig et al. 2013 [ | Mandible | RCT | 5 years | 34 | 45.2 | Machined | Noble Biocare | 4.3 | — | 63 | 1.3 | 1.4 | — | — |
| Rough microthreaded | Noble Biocare | 4 | — | 70 | 0.6 | 0.7 | — | — | ||||||
|
| ||||||||||||||
| Sánchez-Siles et al. 2016 [ | Maxilla | Retrospective | >10 years | 400 | 53.50 | Machined | BIS Biotech | 3.6/3.9/4.4 | 2.5 | 515 | 1.08 ± 1.27 | 1.12 ± 1.21 | 1.18 ± 1.39 | — |
| Rough | BIS Biotech | 3.6/3.9/4.4 | — | 729 | 2.63 ± 1.61 | 2.39 ± 1.59 | 2.41 ± 1.35 | — | ||||||
|
| ||||||||||||||
| Piao et al. 2009 [ | Maxilla | Prospective | 1 year | 54 | 57.6 | Machined | Restore | — | 3 | 45 | 1.38 ± 0.71 | — | — | 100 |
| Rough | Branemark | — | — | 45 | 1.24 ± 0.36 | — | — | 100 | ||||||
| Rough microthreaded | Hexplant | — | — | 45 | 0.78 ± 0.49 | — | — | 100 | ||||||
|
| ||||||||||||||
| Peñarrocha-Diago et al. 2013 [ | Maxilla | Prospective | 1 year | 18 | 56.9 | Machined | Osseous | 3.75/4.25 | — | 69 | 0.38 ± 0.51 | — | — | 98.6 |
| Rough microthreaded | Inhex | 3.75/4.25 | — | 72 | 0.12 ± 0.17 | — | — | 98.6 | ||||||
|
| ||||||||||||||
| Karlsson et al. 1998 [ | Maxilla | Prospective | 2 years | 50 | 53 | Machined | Astra Tech | 3.5/4 | — | 36 | 0.26 ± 0.81 | — | — | 95.3 |
| Rough | Astra Tech | 3.5/4 | — | 36 | 0.22 ± 0.55 | — | — | 100 | ||||||
|
| ||||||||||||||
| Van de Velde et al. 2010 [ | Mandible | Prospective | 1 year | 39 | 58.4 | Machined | Branemark | — | — | 70 | 1.52 ± 0.64 | — | — | 98.6 |
| Rough | Astra Tech | — | — | 75 | 0.80 ± 0.98 | — | — | 100 | ||||||
| Rough microthreaded | Astra Tech | — | — | 50 | 0.81 ± 1.11 | — | — | 100 | ||||||
|
| ||||||||||||||
| Bratu et al. 2009 [ | Mandible | Prospective | 1 year | 46 | 23–65 | Machined | MIS-Implants | 3.75/4.25 | — | 46 | 1.47 ± 0.4 | — | — | 100 |
| Rough microthreaded | MIS-Implants | 3.75/4.25 | — | 46 | 0.69 ± 0.25 | — | — | 100 | ||||||
|
| ||||||||||||||
| Goswami 2009 [ | Mandible | Prospective | 1 year | 20 | 25–50 | Machined | Oraltronics | — | 2 | 20 | 1.53 ± 0.28 | — | — | — |
| Rough | Nobel Biocare | — | — | 20 | 1.41 ± 0.35 | — | — | — | ||||||
|
| ||||||||||||||
| Shin et al. 2006 [ | Maxilla | Prospective | 1 year | 68 | 48 | Machined | Ankylos | — | — | 35 | 1.32 ± 0.27 | — | — | 100 |
| Rough | Lifecore | — | — | 34 | 0.76 ± 0.21 | — | — | 100 | ||||||
| Rough microthreaded | Oneplant | — | — | 38 | 0.18 ± 0.16 | — | — | 100 | ||||||
|
| ||||||||||||||
| Lee et al. 2007 [ | Maxilla | Prospective | 3 years | 17 | 53.3 | Rough microthreaded | Astra Tech | 3.5/4 | — | 17 | 0.24 ± 0.13 | — | — | 100 |
| Rough | Astra Tech | 3.5/4 | — | 17 | 0.51 ± 0.33 | — | — | 100 | ||||||
|
| ||||||||||||||
| Puchades-Roman et al. 2000 [ | Maxilla | Retrospective | >2 years | 30 | 41.9 | Machined | Astra Tech | — | — | 15 | 1.65 ± (0.26) | — | — | — |
| 37.3 | Rough | Branemark | — | — | 15 | 0.57 ± (0.28) | — | — | — | |||||
Results of quality assessment.
| Quality criteria | Studies | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| den Hartog et al. [ | Nickenig et al. [ | Sánchez-Siles et al. [ | Piao et al. [ | Peñarrocha-Diago et al. [ | Karlsson et al. [ | Van de Velde et al. [ | Bratu et al. [ | Goswami [ | Shin et al. [ | Lee et al. [ | Puchades-Roman et al. [ | |
| (1) Was the study described as random? | Yes | Yes | No | No | Yes | No | Yes | Yes | No | Yes | No | No |
|
| ||||||||||||
| (2) Was the randomization scheme described and appropriate? | Yes | Yes | No | No | Yes | No | Yes | Yes | No | Yes | No | No |
|
| ||||||||||||
| (3) Was the study described as double-blind? | No | No | No | No | No | No | No | No | No | No | No | No |
|
| ||||||||||||
| (4) Was the method of double blinding appropriate? | No | No | No | No | No | No | No | No | No | No | No | No |
|
| ||||||||||||
| (5) Was there a description of dropouts and withdrawals? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
|
| ||||||||||||
| Jadad score | 3 | 3 | 1 | 1 | 3 | 1 | 3 | 3 | 1 | 3 | 1 | 1 |
|
| ||||||||||||
| Quality of study | High | High | Low | Low | High | Low | High | High | Low | High | Low | Low |
Figure 2Forest plot for the event “marginal bone loss” in the comparison between machined and rough-surfaced neck implants (a), machined and rough-surfaced microthreaded neck implants (b), and rough and rough-surfaced microthreaded neck implants (c).
Figure 3Forest plot for the event “survival rate” in the comparison between machined and rough-surfaced neck implants.